Physician profile
Anthony Egger
NPI 1245659887
$14,757.40
in general payments reported to CMS, 2019-2025
9 companies · $2,416 in 2025
The $2,416 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $595 · 2020: $3,000 · 2021: $4,906 · 2022: $1,082 · 2023: $2,611 · 2024: $147 · 2025: $2,416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Travel and Lodging: $1,537 · Food and Beverage: $1,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Travel and Lodging | $1,536.70 |
| Food and Beverage | $1,137.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,250.31 | 2021-2025 | |
| Smith+Nephew, INC. | $3,118.61 | 2020-2022 | |
| United Orthopedics LLC | $454.14 | 2023-2025 | |
| Stryker Corporation | $384.51 | 2019-2025 | Xia 3 |
| Orthopediatrics Corp. | $268.22 | 2019 | |
| Biomarin Pharmaceutical INC. | $91.81 | 2019 | |
| Orthofix Medical, INC. | $87.50 | 2023 | Truelok, Tl-Hex Truelok Hexapod System |
| Nexus Medical Technologies LLC | $68.90 | 2025 | |
| Vericel Corporation | $33.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Egger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.